Pediatric Nephrology

, Volume 27, Issue 4, pp 571–579 | Cite as

Adenine phosphoribosyltransferase deficiency in children

  • Jérôme Harambat
  • Guillaume Bollée
  • Michel Daudon
  • Irène Ceballos-Picot
  • Albert Bensman
  • APRT Study Group
Original Article


Adenine phosphoribosyltransferase (APRT) deficiency is a rare autosomal recessive disorder characterized by 2,8-dihydroxyadenine (2,8-DHA) crystalluria that can cause nephrolithiasis and chronic kidney disease. The aim of our study was to assess the clinical presentation, diagnosis, and outcome of APRT deficiency in a large pediatric cohort. All pediatric cases of APRT deficiency confirmed at the same French reference laboratories between 1978 and 2010 were retrospectively reviewed. Twenty-one patients from 18 families were identified. The median age at diagnosis was 3 years. Diagnosis was made after one or more episodes of nephrolithiasis (17 patients), after urinary tract infection (1 patient), and by family screening (3 patients). The diagnosis was based on stone analysis and microscopic examination of urine and/or enzymatic determination of APRT on red blood cells. All children had null APRT enzyme activity in erythrocytes. APRT gene sequencing was performed on 18 patients, revealing six homozygous and 12 compound heterozygous mutations. At diagnosis, half of the patients had decreased kidney function, and two children presented with acute renal failure. Allopurinol treatment was given to all patients at a median dose of 9 mg/kg/day. After a median follow-up of 5 years, all patients showed stabilization or improvement of kidney function, normal growth and development, and six patients had recurrence of nephrolithiasis. Based on these results, we conclude that an excellent outcome can be achieved in children with APRT deficiency who receive the proper treatment.

Key words

APRT deficiency Inborn error of purine metabolism Nephrolithiasis Chronic kidney disease Children 





Adenine phosphoribosyltransferase


End-stage renal disease


Estimated glomerular filtration rate


Interquartile range


Standard Deviation Score


Urinary tract infection



We sincerely thank Dr. Patrizia Bonneau-Amati (Angers, France), Dr. Ana Medeira, (Lisbon, Portugal) for additional data collection, and Véronique Droin, Lionel Mockel, Cécile Dollinger, Lucile Boutaud, and Delphine Guillemot from the Laboratoire de Biochimie Métabolique, Hôpital Necker-Enfants Malades, Paris, for their technical assistance.


  1. 1.
    Cameron JS, Moro F, Simmonds HA (1993) Gout, uric acid and purine metabolism in paediatric nephrology. Pediatr Nephrol 7:105–118PubMedCrossRefGoogle Scholar
  2. 2.
    Bollée G, Dollinger C, Boutaud L, Guillemot D, Bensman A, Harambat J, Deteix P, Daudon M, Knebelmann B, Ceballos-Picot I (2010) Phenotype and genotype characterization of adenine phosphoribosyltransferase deficiency. J Am Soc Nephrol 21:679–688PubMedCrossRefGoogle Scholar
  3. 3.
    Nasr SH, Sethi S, Cornell LD, Milliner DS, Boelkins M, Broviac J, Fidler ME (2010) Crystalline nephropathy due to 2,8-dihydroxyadeninuria: an under-recognized cause of irreversible renal failure. Nephrol Dial Transplant 25:1909–1915PubMedCrossRefGoogle Scholar
  4. 4.
    Stratta P, Fogazzi GB, Canavese C, Airoldi A, Fenoglio R, Bozzola C, Ceballos-Picot I, Bollée G, Daudon M (2010) Decreased kidney function and crystal deposition in the tubules after kidney transplant. Am J Kidney Dis 56:585–590PubMedCrossRefGoogle Scholar
  5. 5.
    Gagné ER, Deland E, Daudon M, Noël LH, Nawar T (1994) Chronic renal failure secondary to 2,8-dihydroxyadenine deposition: the first report of recurrence in a kidney transplant. Am J Kidney Dis 24:104–107PubMedGoogle Scholar
  6. 6.
    Eller P, Rosenkranz AR, Mark W, Theurl I, Laufer J, Lhotta K (2004) Four consecutive renal transplantations in a patient with adenine phosphoribosyltransferase deficiency. Clin Nephrol 61:217–221PubMedGoogle Scholar
  7. 7.
    Edvardsson V, Palsson R, Olafsson I, Hjaltadottir G, Laxdal T (2001) Clinical features and genotype of adenine phosphoribosyltransferase deficiency in Iceland. Am J Kidney Dis 38:473–480PubMedCrossRefGoogle Scholar
  8. 8.
    Greenwood MC, Dillon MJ, Simmonds HA, Barratt TM, Pincott JR, Metreweli C (1982) Renal failure due to 2,8-dihydroxyadenine urolithiasis. Eur J Pediatr 138:346–349PubMedCrossRefGoogle Scholar
  9. 9.
    Van Acker KJ, Simmonds HA, Potter C, Cameron JS (1977) Complete deficiency of adenine phosphoribosyltransferase. Report of a family. N Engl J Med 297:127–132PubMedCrossRefGoogle Scholar
  10. 10.
    Barratt TM, Simmonds HA, Cameron JS, Potter CF, Rose GA, Arkell DG, Williams DI (1979) Complete deficiency of adenine phosphoribosyltransferase: a third case presenting as renal stones in a young child. Arch Dis Child 54:25–31PubMedCrossRefGoogle Scholar
  11. 11.
    Deng L, Yang M, Fründ S, Wessel T, De Abreu RA, Tischfield JA, Sahota A (2001) 2,8-Dihydroxyadenine urolithiasis in a patient with considerable residual adenine phosphoribosyltransferase activity in cell extracts but with mutations in both copies of APRT. Mol Genet Metab 72:260–264PubMedCrossRefGoogle Scholar
  12. 12.
    Ceballos-Picot I, Guest G, Moriniere V, Mockel L, Daudon M, Malan V, Antignac C, Heidet L (2011) Maternal uniparental disomy of chromosome 16 in a patient with adenine phosphoribosyltransferase deficiency. Clin Genet 80:199–201PubMedCrossRefGoogle Scholar
  13. 13.
    Schwartz GJ, Feld LG, Langford DJ (1984) A simple estimate of glomerular filtration rate in full-term infants during the first year of life. J Pediatr 104:849–854PubMedCrossRefGoogle Scholar
  14. 14.
    Schwartz GJ, Muñoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–637PubMedCrossRefGoogle Scholar
  15. 15.
    Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, Van Lente F, Collaboration Chronic Kidney Disease Epidemiology (2007) Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 53:766–772PubMedCrossRefGoogle Scholar
  16. 16.
    Sempé M, Pédron G, Roy-Pernot MP (1979) Auxologie méthode et séquences. Théraplix, ParisGoogle Scholar
  17. 17.
    Daudon M, Jungers P (2004) Clinical value of crystalluria and quantitative morphoconstitutional analysis of urinary calculi. Nephron Physiol 98:31–36CrossRefGoogle Scholar
  18. 18.
    Ceballos-Picot I, Mockel L, Potier MC, Dauphinot L, Shirley TL, Torero-Ibad R, Fuchs J, Jinnah HA (2009) Hypoxanthine-guanine phosphoribosyl transferase regulates early developmental programming of dopamine neurons: implications for Lesch-Nyhan disease pathogenesis. Hum Mol Genet 18:2317–2327PubMedCrossRefGoogle Scholar
  19. 19.
    Ceballos-Picot I, Perignon JL, Hamet M, Daudon M, Kamoun P (1992) 2,8-Dihydroxyadenine urolithiasis, an underdiagnosed disease. Lancet 339:1050–1051PubMedCrossRefGoogle Scholar
  20. 20.
    Sahota A, Tischfield J, Kamatani N, Simmonds HA (2001) Adenine phosphoribosyltransferase deficiency and 2,8-dihydroxyadenine lithiasis. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited diseases, 8th edn. McGraw-Hill, New York, pp 2571–84.Google Scholar
  21. 21.
    Broderick TP, Schaff DA, Bertino AM, Dush MK, Tischfield JA, Stambrook PJ (1987) Comparative anatomy of the human APRT gene and enzyme: nucleotide sequence divergence and conservation of a nonrandom CpG dinucleotide arrangement. Proc Natl Acad Sci USA 84:3349–3353PubMedCrossRefGoogle Scholar
  22. 22.
    Tischfield JA, Ruddle FH (1974) Assignment of the gene for adenine phosphoribosyltransferase to human chromosome 16 by mouse-human somatic cell hybridization. Proc Natl Acad Sci USA 71:45–49PubMedCrossRefGoogle Scholar
  23. 23.
    Chen J, Sahota A, Laxdal T, Scrine M, Bowman S, Cui C, Stambrook PJ, Tischfield JA (1991) Identification of a single missense mutation in the adenine phosphoribosyltransferase (APRT) gene from five Icelandic patients and a British patient. Am J Hum Genet 49:1306–1311PubMedGoogle Scholar
  24. 24.
    Hidaka Y, Tarlé SA, Fujimori S, Kamatani N, Kelley WN, Palella TD (1988) Human adenine phosphoribosyltransferase deficiency. Demonstration of a single mutant allele common to the Japanese. J Clin Invest 81:945–950PubMedCrossRefGoogle Scholar
  25. 25.
    Kamatani N, Terai C, Kuroshima S, Nishioka K, Mikanagi K (1987) Genetic and clinical studies on 19 families with adenine phosphoribosyltransferase deficiencies. Hum Genet 75:163–168PubMedCrossRefGoogle Scholar
  26. 26.
    Iwaki T, Kusaka T, Ohashi I, Nishida T, Imai T, Itoh S (2010) Two families with compound heterozygosity for adenine phosphoribosyltransferase deficiency. Pediatr Nephrol 25:1173–1176PubMedCrossRefGoogle Scholar
  27. 27.
    Kamatani N, Hakoda M, Otsuka S, Yoshikawa H, Kashiwazaki S (1992) Only three mutations account for almost all defective alleles causing adenine phosphoribosyltransferase deficiency in Japanese patients. J Clin Invest 90:130–135PubMedCrossRefGoogle Scholar
  28. 28.
    Suzuki K, Kobayashi S, Kawamura K, Kuhara T, Tsugawa R (1997) Family study of 2,8-dihydroxyadenine stone formation: report of two cases of a compound heterozygote for adenine phosphoribosyltransferase deficiency (APRT*J/APRT*Q0). Int J Urol 4:304–306PubMedCrossRefGoogle Scholar
  29. 29.
    Vernon HJ, Osborne C, Tzortzaki EG, Yang M, Chen J, Rittling SR, Denhardt DT, Buyske S, Bledsoe SB, Evan AP, Fairbanks L, Simmonds HA, Tischfield JA, Sahota A (2005) Aprt/Opn double knockout mice: osteopontin is a modifier of kidney stone disease severity. Kidney Int 68:938–947PubMedCrossRefGoogle Scholar
  30. 30.
    Engle SJ, Stockelman MG, Chen J, Boivin G, Yum MN, Davies PM, Ying MY, Sahota A, Simmonds HA, Stambrook PJ, Tischfield JA (1996) Adenine phosphoribosyltransferase-deficient mice develop 2,8-dihydroxyadenine nephrolithiasis. Proc Natl Acad Sci USA 93:5307–5312PubMedCrossRefGoogle Scholar
  31. 31.
    Evan AP, Bledsoe SB, Connors BA, Deng L, Liang L, Shao C, Fineberg NS, Grynpas MD, Stambrook PJ, Youzhi S, Sahota A, Tischfield JA (2001) Sequential analysis of kidney stone formation in the Aprt knockout mouse. Kidney Int 60:910–923PubMedCrossRefGoogle Scholar

Copyright information

© IPNA 2011

Authors and Affiliations

  • Jérôme Harambat
    • 1
    • 6
  • Guillaume Bollée
    • 2
  • Michel Daudon
    • 3
  • Irène Ceballos-Picot
    • 4
  • Albert Bensman
    • 5
  • APRT Study Group
  1. 1.Service de Pédiatrie, Centre Hospitalier Universitaire de BordeauxCentre de référence Maladies Rénales Rares du Sud OuestBordeauxFrance
  2. 2.Service de Néphrologie, Hôpital Necker-Enfants Malades, Assistance Publique–Hôpitaux de Paris (APHP)Université Descartes, Sorbonne Paris CitéParisFrance
  3. 3.Laboratoire de Biochimie A, Hôpital Necker-Enfants Malades, APHPUniversité Descartes, Sorbonne Paris CitéParisFrance
  4. 4.Laboratoire de Biochimie Métabolique, Hôpital Necker-Enfants Malades, APHPUniversité Descartes, Sorbonne Paris CitéParisFrance
  5. 5.Service de Néphrologie Pédiatrique, Hôpital Armand Trousseau, APHPUniversité Pierre et Marie CurieParisFrance
  6. 6.Hôpital Pellegrin-EnfantsBordeaux CedexFrance

Personalised recommendations